Estradiol increases neural-specific class II-β-tubulin mRNA levels in the developing female hypothalamus by regulating mRNA stability

Lisa C. Rogers, Ian De Boer, Marie Pierre Junier, Sergio Ojeda

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    Estradiol has been shown to act in the central nervous system to promote neuronal growth, differentiation, and synaptic plasticity. Recent evidence indicates that estrogens exert these effects by enhancing the expression of genes that encode key proteins of the neuronal cytoskeleton and synaptic membranes. In a previous report, we demonstrated a sex-related difference in the developmental expression of Class II β-tubulin (RBT1) mRNA, which encodes a neural-specific tubulin isotype. This difference, not shared by Class IV β-tubulin mRNA or the mRNAs encoding neurofilament proteins, was restricted to the hypothalamus. RBT1 mRNA levels were found to decrease in both sexes during postnatal development, but significantly earlier in females than in males, suggesting that the difference is steroid-dependent. The present experiments demonstrate that 17β-estradiol increases, in a stereospecific manner, RBT1 mRNA levels in the hypothalamus of developing female rats. The effect was also region-specific, as it was not detected in either the cerebral cortex or the cerebellum. The increase in RBT1 mRNA levels was observed after either in vivo administration of 17β-estradiol or in vitro exposure of the hypothalamus to the steroid, and it was evident during both neonatal-infantile development (4 to 12 days of age) and near the time of puberty (29 days of age). The effect was detected by RNA blot hybridization and verified by a sensitive, sequence-specific ribonuclease (RNase) protection assay. In vitro exposure of hypothalamic fragments containing the arcuate/ventromedial nucleus-median eminence region of 28-day-old animals to 17β-estradiol prevented the decline in RBT1 mRNA levels that follows selective blockade of mRNA synthesis via pharmacological inhibition of RNA polymerase II. The results suggest that the neurotrophic effects exerted by 17β-estradiol during early postnatal development of the hypothalamus and in the arcuate/ventromedial nuclei at the time of puberty are, at least in part, mediated by an increase in RBT1 mRNA levels, the consequence of an estradiol-dependent increase in RBT1 mRNA stability.

    Original languageEnglish (US)
    Pages (from-to)424-431
    Number of pages8
    JournalMolecular and Cellular Neuroscience
    Volume4
    Issue number5
    StatePublished - 1993

    Fingerprint

    RNA Stability
    Tubulin
    Hypothalamus
    Estradiol
    Messenger RNA
    Arcuate Nucleus of Hypothalamus
    Puberty
    Steroids
    Neurofilament Proteins
    Synaptic Membranes
    Median Eminence
    Neuronal Plasticity
    RNA Polymerase II
    Ribonucleases
    Cytoskeleton
    Sex Characteristics
    Cerebral Cortex
    Cerebellum
    Estrogens
    Central Nervous System

    ASJC Scopus subject areas

    • Molecular Biology
    • Cellular and Molecular Neuroscience
    • Developmental Neuroscience

    Cite this

    Estradiol increases neural-specific class II-β-tubulin mRNA levels in the developing female hypothalamus by regulating mRNA stability. / Rogers, Lisa C.; De Boer, Ian; Junier, Marie Pierre; Ojeda, Sergio.

    In: Molecular and Cellular Neuroscience, Vol. 4, No. 5, 1993, p. 424-431.

    Research output: Contribution to journalArticle

    @article{753cc8aec43e4ee682b23420832ac80d,
    title = "Estradiol increases neural-specific class II-β-tubulin mRNA levels in the developing female hypothalamus by regulating mRNA stability",
    abstract = "Estradiol has been shown to act in the central nervous system to promote neuronal growth, differentiation, and synaptic plasticity. Recent evidence indicates that estrogens exert these effects by enhancing the expression of genes that encode key proteins of the neuronal cytoskeleton and synaptic membranes. In a previous report, we demonstrated a sex-related difference in the developmental expression of Class II β-tubulin (RBT1) mRNA, which encodes a neural-specific tubulin isotype. This difference, not shared by Class IV β-tubulin mRNA or the mRNAs encoding neurofilament proteins, was restricted to the hypothalamus. RBT1 mRNA levels were found to decrease in both sexes during postnatal development, but significantly earlier in females than in males, suggesting that the difference is steroid-dependent. The present experiments demonstrate that 17β-estradiol increases, in a stereospecific manner, RBT1 mRNA levels in the hypothalamus of developing female rats. The effect was also region-specific, as it was not detected in either the cerebral cortex or the cerebellum. The increase in RBT1 mRNA levels was observed after either in vivo administration of 17β-estradiol or in vitro exposure of the hypothalamus to the steroid, and it was evident during both neonatal-infantile development (4 to 12 days of age) and near the time of puberty (29 days of age). The effect was detected by RNA blot hybridization and verified by a sensitive, sequence-specific ribonuclease (RNase) protection assay. In vitro exposure of hypothalamic fragments containing the arcuate/ventromedial nucleus-median eminence region of 28-day-old animals to 17β-estradiol prevented the decline in RBT1 mRNA levels that follows selective blockade of mRNA synthesis via pharmacological inhibition of RNA polymerase II. The results suggest that the neurotrophic effects exerted by 17β-estradiol during early postnatal development of the hypothalamus and in the arcuate/ventromedial nuclei at the time of puberty are, at least in part, mediated by an increase in RBT1 mRNA levels, the consequence of an estradiol-dependent increase in RBT1 mRNA stability.",
    author = "Rogers, {Lisa C.} and {De Boer}, Ian and Junier, {Marie Pierre} and Sergio Ojeda",
    year = "1993",
    language = "English (US)",
    volume = "4",
    pages = "424--431",
    journal = "Molecular and Cellular Neuroscience",
    issn = "1044-7431",
    publisher = "Academic Press Inc.",
    number = "5",

    }

    TY - JOUR

    T1 - Estradiol increases neural-specific class II-β-tubulin mRNA levels in the developing female hypothalamus by regulating mRNA stability

    AU - Rogers, Lisa C.

    AU - De Boer, Ian

    AU - Junier, Marie Pierre

    AU - Ojeda, Sergio

    PY - 1993

    Y1 - 1993

    N2 - Estradiol has been shown to act in the central nervous system to promote neuronal growth, differentiation, and synaptic plasticity. Recent evidence indicates that estrogens exert these effects by enhancing the expression of genes that encode key proteins of the neuronal cytoskeleton and synaptic membranes. In a previous report, we demonstrated a sex-related difference in the developmental expression of Class II β-tubulin (RBT1) mRNA, which encodes a neural-specific tubulin isotype. This difference, not shared by Class IV β-tubulin mRNA or the mRNAs encoding neurofilament proteins, was restricted to the hypothalamus. RBT1 mRNA levels were found to decrease in both sexes during postnatal development, but significantly earlier in females than in males, suggesting that the difference is steroid-dependent. The present experiments demonstrate that 17β-estradiol increases, in a stereospecific manner, RBT1 mRNA levels in the hypothalamus of developing female rats. The effect was also region-specific, as it was not detected in either the cerebral cortex or the cerebellum. The increase in RBT1 mRNA levels was observed after either in vivo administration of 17β-estradiol or in vitro exposure of the hypothalamus to the steroid, and it was evident during both neonatal-infantile development (4 to 12 days of age) and near the time of puberty (29 days of age). The effect was detected by RNA blot hybridization and verified by a sensitive, sequence-specific ribonuclease (RNase) protection assay. In vitro exposure of hypothalamic fragments containing the arcuate/ventromedial nucleus-median eminence region of 28-day-old animals to 17β-estradiol prevented the decline in RBT1 mRNA levels that follows selective blockade of mRNA synthesis via pharmacological inhibition of RNA polymerase II. The results suggest that the neurotrophic effects exerted by 17β-estradiol during early postnatal development of the hypothalamus and in the arcuate/ventromedial nuclei at the time of puberty are, at least in part, mediated by an increase in RBT1 mRNA levels, the consequence of an estradiol-dependent increase in RBT1 mRNA stability.

    AB - Estradiol has been shown to act in the central nervous system to promote neuronal growth, differentiation, and synaptic plasticity. Recent evidence indicates that estrogens exert these effects by enhancing the expression of genes that encode key proteins of the neuronal cytoskeleton and synaptic membranes. In a previous report, we demonstrated a sex-related difference in the developmental expression of Class II β-tubulin (RBT1) mRNA, which encodes a neural-specific tubulin isotype. This difference, not shared by Class IV β-tubulin mRNA or the mRNAs encoding neurofilament proteins, was restricted to the hypothalamus. RBT1 mRNA levels were found to decrease in both sexes during postnatal development, but significantly earlier in females than in males, suggesting that the difference is steroid-dependent. The present experiments demonstrate that 17β-estradiol increases, in a stereospecific manner, RBT1 mRNA levels in the hypothalamus of developing female rats. The effect was also region-specific, as it was not detected in either the cerebral cortex or the cerebellum. The increase in RBT1 mRNA levels was observed after either in vivo administration of 17β-estradiol or in vitro exposure of the hypothalamus to the steroid, and it was evident during both neonatal-infantile development (4 to 12 days of age) and near the time of puberty (29 days of age). The effect was detected by RNA blot hybridization and verified by a sensitive, sequence-specific ribonuclease (RNase) protection assay. In vitro exposure of hypothalamic fragments containing the arcuate/ventromedial nucleus-median eminence region of 28-day-old animals to 17β-estradiol prevented the decline in RBT1 mRNA levels that follows selective blockade of mRNA synthesis via pharmacological inhibition of RNA polymerase II. The results suggest that the neurotrophic effects exerted by 17β-estradiol during early postnatal development of the hypothalamus and in the arcuate/ventromedial nuclei at the time of puberty are, at least in part, mediated by an increase in RBT1 mRNA levels, the consequence of an estradiol-dependent increase in RBT1 mRNA stability.

    UR - http://www.scopus.com/inward/record.url?scp=0027428309&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0027428309&partnerID=8YFLogxK

    M3 - Article

    C2 - 19912949

    AN - SCOPUS:0027428309

    VL - 4

    SP - 424

    EP - 431

    JO - Molecular and Cellular Neuroscience

    JF - Molecular and Cellular Neuroscience

    SN - 1044-7431

    IS - 5

    ER -